Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05173935 · ClinicalTrials.gov registry record · NA
Complications Associated With Primary Placement of Gastrostomy for Feeding
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT05173935: Completed NA study, sponsored by Mayo Clinic.
NCT05173935 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05173935, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of the study is to compare pain, complications, and quality of life after gastrostomy tube is placed by either percutaneous endoscopic gastrostomy (PEG) or radiologically-inserted gastrostomy (RIG) method.
Primary Outcome
Trajectory of the average pain score over time (question 3, Cleeland Brief Pain Inventory), which rates average pain in the past 24 hours, with 0 being no pain and 10 being pain as bad as can be imagined
Interventions
- PROCEDURE Percutaneous endoscopic gastrostomy
- PROCEDURE Radiologically-inserted gastrostomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2017-12-08 |
| Est. Completion | 2021-07-29 |
| Phase | NA |
What the finished NCT05173935 record still lists
NCT05173935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Percutaneous endoscopic gastrostomy is the first listed.
NCT05173935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05173935 about?
NCT05173935 is a clinical study titled "Complications Associated With Primary Placement of Gastrostomy for Feeding". The purpose of the study is to compare pain, complications, and quality of life after gastrostomy tube is placed by either percutaneous endoscopic gastrostomy (PEG) or radiologically-inserted gastrostomy (RIG) method.
What is the current status of trial NCT05173935?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2017-12-08. Estimated completion is 2021-07-29.
What interventions are being tested in trial NCT05173935?
The interventions under investigation include: Percutaneous endoscopic gastrostomy (PROCEDURE), Radiologically-inserted gastrostomy (PROCEDURE).
Who is sponsoring clinical trial NCT05173935?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05173935's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI